Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Finished Goods (2020 - 2022)

Rapid Micro Biosystems' Finished Goods history spans 3 years, with the latest figure at $8.0 million for Q2 2022.

  • For Q2 2022, Finished Goods rose 165.47% year-over-year to $8.0 million; the TTM value through Jun 2022 reached $8.0 million, up 165.47%, while the annual FY2021 figure was $4.3 million, 321.25% up from the prior year.
  • Finished Goods for Q2 2022 was $8.0 million at Rapid Micro Biosystems, up from $5.9 million in the prior quarter.
  • Across five years, Finished Goods topped out at $8.0 million in Q2 2022 and bottomed at $1.0 million in Q4 2020.
  • The 3-year median for Finished Goods is $3.7 million (2021), against an average of $4.2 million.
  • The largest annual shift saw Finished Goods skyrocketed 321.25% in 2021 before it skyrocketed 165.47% in 2022.
  • A 3-year view of Finished Goods shows it stood at $1.0 million in 2020, then surged by 321.25% to $4.3 million in 2021, then soared by 86.28% to $8.0 million in 2022.
  • Per Business Quant, the three most recent readings for RPID's Finished Goods are $8.0 million (Q2 2022), $5.9 million (Q1 2022), and $4.3 million (Q4 2021).